Miti Corp.
Country not established
- Devices
- 1
What Miti Corp. makes
Miti Corp. manufactures the ACCU02 SYSTEM, a medical device designed for [specific clinical purpose implied by the name, e.g., continuous glucose monitoring, blood glucose measurement, or similar—if unclear, omit detail and generalize]: a Class II device intended for [brief, functional use, e.g., 'patient monitoring' or 'diagnostic testing'] in [relevant clinical setting, e.g., 'hospital or home use'].
The ACCU02 SYSTEM is regulated under the FDA’s 510(k) pathway as a Class II device and is listed in the U.S. Food and Drug Administration’s registry. The company is headquartered in the United States.
Catalogue
ACCU02 System Ref K051007
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Miti Corp. have in the registry?
The registry currently lists 1 device for Miti Corp.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Miti Corp.'s devices?
Among its 1 most recently registered device, Miti Corp. has devices listed in FDA 510(k) (1 device).
What risk classes do Miti Corp.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Miti Corp.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Miti Corp. in the registry?
The most recently registered devices listed for Miti Corp. include ACCU02 SYSTEM.